Swiss drugmaker Novartis AG is buying Gyroscope Therapeutics for up to $1.5 billion, looking to bolster its gene therapy roster with the British firm's treatment for geographic atrophy, a leading cause of blindness.
is buying Gyroscope Therapeutics for up to $1.5 billion, looking to bolster its gene therapy roster with the British firm's treatment for geographic atrophy, a leading cause of blindness., said on Wednesday that Novartis will pay $800 million upfront and up to $700 million in additional milestone payments.
Gyroscope's treatment for geographic atrophy, a disease of the retina that leads to blindness and for which there is currently no treatment, is in the second phase of clinical development.Gene therapies are currently among the world's most expensive drugs. They aim to cure diseases by replacing the missing or defective version of a gene in a patient's cells with an intact gene.
Syncona will also receive low single-digit royalty from future sales of Gyroscope's gene therapy, and cash proceeds of 334 million pounds for its stake in the unit. The deal, which Novartis plans to fund with cash in hand, comes after the Swiss drugmaker raised $20.7 billion by selling a nearly one-third voting stake in Roche last month.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Men’s Earrings: Why Even Lawyers and Accountants Are Embracing Studs and HoopsAs seen on celebs like Harry Styles and Evan Mock, men’s earrings have become increasingly accepted in the past year.
Weiterlesen »
Tesla's Musk says he will pay over $11 bln in taxes this yearElectric-car maker Tesla Inc's Chief Executive Officer Elon Musk said on Sunday on Twitter that he will pay more than $11 billion in taxes this year.
Weiterlesen »
Packaging maker Sonoco to acquire Ball Metalpack for $1.35 blnPackaging products provider Sonoco Products Co said on Monday it will buy sustainable metal packaging manufacturer Ball Metalpack for $1.35 billion in cash to expand its sustainable packing portfolio.
Weiterlesen »
(OFFICIAL) Embraer flying taxi unit Eve, valued at $2.9 bln, to list on NYSEBrazilian planemaker Embraer SA has agreed to combine its electric aircraft subsidiary Eve with Zanite SPAC and list it on NYSE, the companies said on Tuesday.
Weiterlesen »
Eyes Wide Shut Christmas Cards, Get Your Eyes Wide Shut Christmas Cards HereThe question is not, 'Is Eyes Wide Shut a Christmas movie?,' but, 'Will Eyes Wide Shut make your spirit brighter this Christmastime?'
Weiterlesen »
BeiGene to receive up to $1 billion in oncology deal with NovartisBeiGene Ltd. undefined said Monday it had entered an agreement with Swiss drug company Novartis Pharma AG undefined to develop its investigational TIGIT...
Weiterlesen »